Published in Gene Therapy Weekly, November 4th, 1996
The ultimate aim of the work is to develop methods for treating cancer and other diseases. The program involves simultaneous research activities carried out at the Department of Radiation Oncology of Stanford and the Edward L. Ginzton Research Center of Varian Associates and at the Cancer Research Group of SRI.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.